Connection

PATRICIA CASTRO to Oligopeptides

This is a "connection" page, showing publications PATRICIA CASTRO has written about Oligopeptides.
Connection Strength

0.056
  1. Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. Cancer Res Commun. 2025 Nov 01; 5(11):2066-2078.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.